Diluted EPS of $2.39 on a GAAP Basis, a Decrease of 12.1 Percent; Adjusted Diluted EPS of $10.12, a Decrease of 8.9 Percent; These Results Include ...

Other recent partnerships in the molecular glue degrader category include Takeda's recent $1 billion-plus link-up with Degron Therapeutics, a $1.46 billion deal between Novo Nordisk and Neomorph ...

January 2025 kicked off with a wave of impactful biotech deals, setting the stage for an exciting year of innovation.

Here is a list of matters listed at NSW Local and Environment Court on Friday. Today's court listings are published as part ...